about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Cytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsThe Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma.Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia.Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells.Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherinTargeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia.Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanismETV6-LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98-HOXA9.Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B.Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells.A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic RegulatorsCXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients.Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.Role and regulation of microRNAs targeting BTK in acute myelogenous leukemia.Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors.
P2860
Q26746104-539C3EAE-6A98-4BF2-906D-C60CA59EFDFDQ26778929-00DF593E-37B8-475D-815D-BE167AC32FB8Q33607950-61BE2B6E-24C7-4451-B968-355CFCFE882DQ35741542-0D5887B8-0A59-4FE9-9FBF-8B8F9C9F7CACQ35979385-24D47E12-741E-4ABA-8AE3-CE8B752102D2Q36118340-5E12AC91-19A9-40E8-850F-73FA644817E7Q36927799-1B61DE2B-CC62-4DEB-8C3A-5FF398B18EEEQ37457673-E1FA4919-1E70-4365-9C91-803FEEDF1256Q37706488-E4527887-A30E-4469-8C9C-53B54C5EC432Q38401664-8266EB6C-80AA-47F4-BB03-CDDF3AD03946Q38723944-A31B514B-6693-410B-9560-877001BA5FD1Q38815360-C0073DBB-CF9F-434E-BACF-9A8D53039641Q38821637-0C9232A5-7A21-4293-8800-AF3D6F5D8221Q41437410-E8251BD2-474C-4308-BD42-770F1245756CQ41999646-C09A72AA-8149-4F8D-8627-6F36C02D9842Q42764236-E0112EE9-1225-4BDC-8960-6E2DAED804E9Q46228932-E30FF86B-6286-405A-88DD-64019F167F07Q49714593-C18C56F6-A0D9-4DB3-A62D-2D6D88954859Q50054874-F36A6D3D-AE6A-4C1B-BCCC-3250D25CDF1DQ50065065-94330C09-A29A-4804-9D4C-670F85789D3EQ50131810-BDCD6801-BE92-4CFD-BFC5-8DE674D8A3AFQ55260504-294D30B5-FA4C-41A5-A3ED-F6EC51DB1DFF
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@ast
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@en
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@nl
type
label
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@ast
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@en
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@nl
prefLabel
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@ast
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@en
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@nl
P2093
P2860
P50
P356
P1433
P1476
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML
@en
P2093
Lyubov Zaitseva
Manar S Shafat
Matthew J Lawes
Megan Y Murray
P2860
P304
P356
10.18632/ONCOTARGET.2479
P407
P577
2014-10-01T00:00:00Z